Efflux Pump and its Inhibitors: Novel Targets to Combat Drug Resistance / Bhawna Chopra, Ashwani Kumar Dhingra
The rapid emergence of resistant bacteria is occurring worldwide, endangering the efficacy of antibiotics, which have transformed medicine and saved millions of lives. Antibiotic resistance has become a major clinical problem today. In addition, multidrug resistance also develops various structurally and functionally unrelated toxic compounds. To overcome this problem, a new target efflux pump was recognized that, if inhibited, reduces the level of resistance or potentiates or produces a synergistic effect in combination with antibiotics. Keeping this in view, the present review article aims to describe the families of efflux pumps and the various natural components to be employed as good efflux pump inhibitors.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Anti-infective agents - 19(2021), 3, Seite 231- |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chopra, Bhawna [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource (21 p) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
KFL00896145X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL00896145X | ||
| 003 | DE-627 | ||
| 005 | 20231128164445.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220316s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)KFL00896145X | ||
| 035 | |a (KFL)prod_DARH_.55AB87ECF771BE235D8FA573EF7ADC0DCCCE7055 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Chopra, Bhawna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Efflux Pump and its Inhibitors: Novel Targets to Combat Drug Resistance |c Bhawna Chopra, Ashwani Kumar Dhingra |
| 264 | 1 | |c 2021 | |
| 300 | |a 1 Online-Ressource (21 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The rapid emergence of resistant bacteria is occurring worldwide, endangering the efficacy of antibiotics, which have transformed medicine and saved millions of lives. Antibiotic resistance has become a major clinical problem today. In addition, multidrug resistance also develops various structurally and functionally unrelated toxic compounds. To overcome this problem, a new target efflux pump was recognized that, if inhibited, reduces the level of resistance or potentiates or produces a synergistic effect in combination with antibiotics. Keeping this in view, the present review article aims to describe the families of efflux pumps and the various natural components to be employed as good efflux pump inhibitors | ||
| 700 | 1 | |a Dhingra, Ashwani Kumar |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anti-infective agents |d Sharjah : Bentham Science, 2012 |g 19(2021), 3, Seite 231- |h Online-Ressource |w (DE-627)KFL000006572 |w (DE-600)2856689-0 |w (DE-576)469947063 |x 2211-3533 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2021 |g number:3 |g pages:231- |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=2211-3525&volume=19&issue=3&spage=231 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-BEJ | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 935 | |i IMPORT_0628_prod_DARH_02 | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2021 |e 3 |h 231- | ||